Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2

Interventions

Oxaliplatin 21Fluorouracil 20Leucovorin 19Capecitabine 18Irinotecan 13Radiotherapy 8Bevacizumab 7Cetuximab 6Folfox protocol 4cediranib 2Radiation 2Psychiatric Rehabilitation 2Octreotide 2Cisplatin 2Chemoradiotherapy 2tipifarnib 1pertuzumab 1olaparib 1mercaptoundecahydrododecaborate 1eniluracil 1durvalumab 1brivanib 1alpha-Tocopherol 1Watchful Waiting 1Vitamin E 1Trastuzumab 1Tegafur 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Rectal Neoplasms × cediranib × Clear all
NCT00107250 2023-08-04

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Canadian Cancer Trials Group

Phase 1 Completed
50 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00343408 2023-08-04

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Canadian Cancer Trials Group

Phase 1 Completed
31 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡